Mode
Text Size
Log in / Sign up
N/A N=30 Prevention

Effects of Task-Specific Step Training on Reactive Balance

Accidental Fall

Enrolled (actual)
30
Serious AEs
0.0%
Results posted
Sep 2025
Primary outcome: Primary: Trunk Angle at Touchdown of the First Recovery Step — 27.0; 24.6; 28.4 degrees

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
step training (Behavioral); treadmill training (Behavioral)
Age
Older Adult · 65+ yrs
Sex
All
Sponsor
Virginia Polytechnic Institute and State University
Primary completion
Aug 2023

Outcome Measures

OutcomeResultp-value
PRIMARY
Trunk Angle at Touchdown of the First Recovery Step
27.0; 24.6; 28.4
PRIMARY
Trip Outcome
4; 10; 8
SECONDARY
Recovery Step Length
49.5; 45.4; 40.1
SECONDARY
Sacrum Height at Touchdown of the First Recovery Step
97.4; 96.7; 97.7
SECONDARY
Gait Speed
1.6; 1.5; 1.5
SECONDARY
Average Step Speed
1.7; 1.6; 1.4
SECONDARY
Trip Recovery Strategy
12; 12; 13

Summary

The goal of this clinical trial is to evaluate a novel and pragmatic (i.e., not requiring specialized equipment) task-specific step training regimen that aims to improve reactive balance after tripping. The main questions it aims to answer are: * Does this step training regimen improve reactive balance after tripping compared to no training? * How well does this step training regimen improve reactive balance compared to treadmill training, which is a more commonly studied reactive balance training regimen that uses a specialized treadmill. Participants will: * complete step training or treadmill training (or no training if assigned to the control group) twice a week for three weeks * experience a laboratory-induced trip three weeks later to evaluate their reactive balance

Eligibility Criteria

Inclusion Criteria

  • 65-80 years old
  • willing to use wearable sensors for 2-3 weeks (for a separate study)
  • no lower limb amputation
  • not weigh over 250 pounds
  • pass a telephone interview related to cognitive status

Exclusion Criteria

  • participants must pass a health screening involving a questionnaire that will be reviewed by a health care specialist.
  • participants must not have clinical osteoporosis as indicated by a bone mineral density of the lumbar vertebra and proximal femur of t<-2.0 as obtained from dual energy x-ray absorptiometry (DEXA), or a DEXA scan completed within the last year.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05734443). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search